Evidence map›Paper›PMID 35621644›Full record

ReviewCurrent oncology (Toronto, Ont.)2022

Progressing Vulvar Melanoma Caused by Instability in cKIT Juxtamembrane Domain: A Case Report and Review of Literature.

Monika Englert-Golon, Bartłomiej Budny, Małgorzata Lewandowska, Bartosz Burchardt, Natalia Smolarek, Katarzyna Ziemnicka, Paweł Piotr Jagodziński, Marek Ruchała, Marlena Grabowska, Stefan Sajdak

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Monika Englert-GolonDivision of Gynecological, Surgery Department of Gynaecology Obstetrics and Gynaecological Oncology, Poznan University of Medical Sciences, 60-535 Poznan, Poland.ORCID 0000-0003-0569-3179
Bartłomiej BudnyDepartment of Endocrinology Metabolism and Internal Diseases, Poznan University of Medical Sciences, 60-356 Poznan, Poland.ORCID 0000-0002-2860-395X
Małgorzata LewandowskaDivision of Gynecological, Surgery Department of Gynaecology Obstetrics and Gynaecological Oncology, Poznan University of Medical Sciences, 60-535 Poznan, Poland.ORCID 0000-0001-8613-4955
Bartosz BurchardtDivision of Gynecological, Surgery Department of Gynaecology Obstetrics and Gynaecological Oncology, Poznan University of Medical Sciences, 60-535 Poznan, Poland.ORCID 0000-0002-4772-6728
Natalia SmolarekDivision of Gynecological, Surgery Department of Gynaecology Obstetrics and Gynaecological Oncology, Poznan University of Medical Sciences, 60-535 Poznan, Poland.
Katarzyna ZiemnickaDepartment of Endocrinology Metabolism and Internal Diseases, Poznan University of Medical Sciences, 60-356 Poznan, Poland.ORCID 0000-0001-5377-8834
Paweł Piotr JagodzińskiDepartment of Biochemistry and Molecular Biology, Poznan University of Medical Sciences, 60-781 Poznan, Poland.ORCID 0000-0002-9046-6802
Marek RuchałaDepartment of Endocrinology Metabolism and Internal Diseases, Poznan University of Medical Sciences, 60-356 Poznan, Poland.ORCID 0000-0002-6296-7220
Marlena GrabowskaDivision of Gynecological, Surgery Department of Gynaecology Obstetrics and Gynaecological Oncology, Poznan University of Medical Sciences, 60-535 Poznan, Poland.ORCID 0000-0001-6295-713X
Stefan SajdakDivision of Gynecological, Surgery Department of Gynaecology Obstetrics and Gynaecological Oncology, Poznan University of Medical Sciences, 60-535 Poznan, Poland.
Poznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to identify the molecular pathways governing melanoma and track its progression, the next-generation sequencing (NGS) approach and targeted sequencing of cancer genes were employed. The primary tumor, as well as metastatic tissue, of an 84-year-old patient diagnosed with vulvar melanoma (VM), were investigated. The primary tumor specimen showed multiple somatic mutations in

Indexed as

MelanomaSkin NeoplasmsAged, 80 and overHumansMAP Kinase Signaling SystemMutationProto-Oncogene Proteins B-rafProto-Oncogene Proteins B-rafmelanomaNGSrecurrencevulvar neoplasms

Identifiers

PMID35621644
PMCPMC9139488
OpenAlexW4225113048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.